Wakabayashi T (2026). [PMID: 40553882](https://pubmed.ncbi.nlm.nih.gov/40553882/). *Ophthalmol Retina*. [Gene Therapy / Novel Therapeutics]
Hamadmad S (2026). [PMID: 41544460](https://pubmed.ncbi.nlm.nih.gov/41544460/). *Biomed Pharmacother*. [Clinical Trial Publication]
Felfeli T (2026). [PMID: 40811828](https://pubmed.ncbi.nlm.nih.gov/40811828/). *Retina*. [Epidemiology / Natural History]
Kocak I (2026). [PMID: 40967512](https://pubmed.ncbi.nlm.nih.gov/40967512/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Nitzan I (2026). [PMID: 42061571](https://pubmed.ncbi.nlm.nih.gov/42061571/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Erkan E (2026). [PMID: 41579159](https://pubmed.ncbi.nlm.nih.gov/41579159/). *Int Ophthalmol*. [Clinical Trial Publication]
Kawamata Y (2026). [PMID: 41960964](https://pubmed.ncbi.nlm.nih.gov/41960964/). *Invest Ophthalmol Vis Sci*. [Diagnostic / Biomarker]
Zheng F (2026). [PMID: 41802545](https://pubmed.ncbi.nlm.nih.gov/41802545/). *Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)*. [Review / Meta-Analysis]
Hammer M (2026). [PMID: 40999813](https://pubmed.ncbi.nlm.nih.gov/40999813/). *Adv Healthc Mater*. [Basic Science / Preclinical]
Huang Y (2026). [PMID: 41529022](https://pubmed.ncbi.nlm.nih.gov/41529022/). *PLoS One*. [Basic Science / Preclinical]
